Global Neuroimaging Software Market Growth (Status and Outlook) 2026-2032
The global Neuroimaging Software market size is predicted to grow from US$ 1297 million in 2025 to US$ 2635 million in 2032; it is expected to grow at a CAGR of 10.7% from 2026 to 2032.
Neuroimaging Software refers to specialized medical software used to process, quantify, visualize, interpret, and manage analytical outputs derived from imaging of the brain and central nervous system. The market primarily covers software applied to MRI and its advanced sequences, CT/CTA/CTP, PET, SPECT, and multimodal neuroimaging datasets. Core capabilities include image registration and correction, automated tissue and lesion segmentation, brain volumetry and morphometry, perfusion analysis, diffusion and tractography processing, functional brain mapping, molecular imaging quantification, longitudinal change assessment, AI-assisted abnormality detection, and structured reporting. Commercial products are delivered through on-premise workstations, server-based applications, cloud or SaaS platforms, identifiable advanced post-processing modules integrated into imaging environments, and specialized analytical platforms supporting clinical trials and neuroscience research. Neuroimaging Software is primarily used in stroke and cerebrovascular disease, Alzheimer’s disease and other neurodegenerative disorders, multiple sclerosis, neuro-oncology, epilepsy, neurosurgical planning, functional brain assessment, and CNS drug development. The market is characterized by a combination of regulated clinical software, specialized quantitative imaging tools, AI-enabled decision-support applications, and research-oriented commercial platforms.
Stroke and cerebrovascular imaging remain commercially established applications, while neurodegenerative monitoring is becoming a more important source of incremental demand
MRI-based quantification is expanding from diagnostic assessment toward treatment eligibility, longitudinal monitoring and ARIA evaluation
Value is created when raw imaging data are converted into quantitative measurements, biomarkers, workflow prioritization, treatment-planning information or longitudinal evidence that improves decision consistency and reduces manual analytical work. Downstream users include hospitals, imaging centers, neurology and neurosurgery departments, pharmaceutical and biotechnology companies, CROs and research institutions. Cost structures are dominated by software R&D, clinical validation, regulatory compliance, data acquisition and curation, cloud infrastructure, cybersecurity, integration, sales and implementation. As deployment moves toward recurring SaaS and enterprise models, scalable software economics become more important, but clinical support, integration and regulatory maintenance remain meaningful cost components.
The fastest-evolving opportunity set is concentrated around quantitative and treatment-linked applications rather than basic image viewing. Automated brain segmentation, hippocampal and regional volumetry, cortical and lesion measurement, ARIA assessment and longitudinal change analysis are becoming increasingly differentiated commercial functions. CMS documentation recognizes multiple FDA-cleared products addressing automated labeling, visualization and volumetric quantification of brain MRI, as well as dedicated ARIA analysis, supporting the emergence of a more defined regulated quantitative-neuroimaging segment. Functional MRI, DTI, tractography, connectomics and molecular neuroimaging remain smaller but technically differentiated segments with strong relevance in neurosurgery, research and CNS drug development.
Asia-Pacific is becoming more strategically important but remains structurally fragmented. Japan combines global imaging OEMs with domestic neurological AI developers, while South Korea has developed a relatively dense cluster of specialist brain-imaging AI companies focused on volumetry, stroke, Parkinson’s disease, intracranial hemorrhage and cerebrovascular analysis. China has a growing medical-AI ecosystem, although the stricter product-evidence standard applied in this study results in a smaller Core Formal List than in Europe or North America. Taiwan and Australia contribute several niche vendors in diffusion MRI, brain metastasis analysis, perfusion and quantitative neuroimaging. The regional opportunity therefore lies less in simple geographic expansion and more in localization, regulatory approval, hospital integration and adaptation to country-specific clinical workflows.
This Insight Report provides a comprehensive analysis of the global Neuroimaging Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neuroimaging Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neuroimaging Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuroimaging Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuroimaging Software.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuroimaging Software market by product type, application, key players and key regions and countries.
Neuroimaging Software refers to specialized medical software used to process, quantify, visualize, interpret, and manage analytical outputs derived from imaging of the brain and central nervous system. The market primarily covers software applied to MRI and its advanced sequences, CT/CTA/CTP, PET, SPECT, and multimodal neuroimaging datasets. Core capabilities include image registration and correction, automated tissue and lesion segmentation, brain volumetry and morphometry, perfusion analysis, diffusion and tractography processing, functional brain mapping, molecular imaging quantification, longitudinal change assessment, AI-assisted abnormality detection, and structured reporting. Commercial products are delivered through on-premise workstations, server-based applications, cloud or SaaS platforms, identifiable advanced post-processing modules integrated into imaging environments, and specialized analytical platforms supporting clinical trials and neuroscience research. Neuroimaging Software is primarily used in stroke and cerebrovascular disease, Alzheimer’s disease and other neurodegenerative disorders, multiple sclerosis, neuro-oncology, epilepsy, neurosurgical planning, functional brain assessment, and CNS drug development. The market is characterized by a combination of regulated clinical software, specialized quantitative imaging tools, AI-enabled decision-support applications, and research-oriented commercial platforms.
Key Findings
Europe has the densest specialist supplier base, while North America combines major imaging platforms with leading neurovascular and surgical-planning vendorsStroke and cerebrovascular imaging remain commercially established applications, while neurodegenerative monitoring is becoming a more important source of incremental demand
MRI-based quantification is expanding from diagnostic assessment toward treatment eligibility, longitudinal monitoring and ARIA evaluation
Market Trends
Neuroimaging Software is shifting from isolated post-processing tools and single-purpose algorithms toward integrated, multimodal and longitudinal analytical workflows. MRI remains central to quantitative brain analysis, while CT-based stroke applications, PET and SPECT quantification, diffusion imaging, functional MRI and multimodal fusion broaden the addressable clinical workflows. Product development is increasingly focused on automated segmentation, quantitative biomarkers, longitudinal comparison, structured reporting and cloud-enabled delivery rather than stand-alone visualization alone. The expansion of disease-modifying therapies for Alzheimer’s disease is also strengthening the role of quantitative MRI and treatment-safety monitoring. In August 2025, the U.S. FDA required an additional earlier MRI monitoring point for patients receiving lecanemab because of ARIA risk, reinforcing the importance of repeatable brain-image assessment during therapy. At the same time, consolidation is accelerating as larger imaging and digital-health groups acquire specialized analytical technologies: GE HealthCare completed its acquisition of icometrix in 2025, SyntheticMR completed its acquisition of Combinostics, and RadNet acquired Gleamer for integration into DeepHealth in March 2026.Market Dynamics
Drivers
Demand for Neuroimaging Software is being supported by the rising clinical need for faster and more standardized interpretation of complex neurological imaging, together with increasing use of quantitative biomarkers in stroke, dementia, multiple sclerosis, neuro-oncology and neurosurgical planning. Hospital systems are seeking tools that reduce manual measurement, improve consistency across readers and accelerate time-sensitive workflows, particularly in acute stroke. Another important driver is the growing role of imaging in treatment selection and safety monitoring for neurodegenerative therapies. FDA requirements for additional MRI monitoring during lecanemab therapy illustrate how imaging is becoming more closely connected to longitudinal therapeutic management rather than one-time diagnosis alone. CNS drug development also creates demand for standardized MRI and PET analysis across sites and time points, supporting specialized clinical-trial imaging and biomarker platforms.Restraints
Market adoption remains constrained by fragmented reimbursement, lengthy hospital procurement cycles, regulatory requirements, interoperability issues and the cost of integrating analytical software into existing radiology and clinical workflows. Neuroimaging algorithms must also perform consistently across scanners, protocols, patient populations and imaging quality levels, increasing the cost of validation and product maintenance. In research-oriented applications, widely used academic and open-source software continues to limit pricing power for commercial vendors. Large imaging OEMs can also bundle advanced post-processing functions into broader workstation or enterprise-imaging contracts, which can reduce the addressable stand-alone software value for independent suppliers. These factors mean that technically strong products do not automatically translate into rapid commercial adoption, particularly where the clinical workflow benefit or reimbursement pathway is not clearly defined.Opportunities
The most attractive opportunities are emerging where Neuroimaging Software moves beyond image visualization to support treatment pathways, measurable biomarkers and longitudinal disease management. Quantitative MRI for Alzheimer’s disease, ARIA assessment, automated brain volumetry, multiple-sclerosis monitoring, PET-based neurodegenerative biomarkers and treatment-response analysis are becoming increasingly relevant. CMS documentation on automated brain MRI detection and quantification identifies regulated commercial products for brain volumetry, ARIA analysis and morphometric assessment, demonstrating that these applications are moving toward identifiable clinical software categories. Additional opportunities exist in vendor-neutral cloud deployment, multimodal MRI/PET analysis, CNS clinical trials, smaller hospitals that lack specialist neuroradiology resources, and emerging Asian markets where domestic medical-AI suppliers are building localized neuroimaging products.Challenges
The principal long-term challenge is converting algorithmic performance into repeatable clinical and economic value. Regulatory clearance alone does not guarantee reimbursement, workflow adoption or sustained usage, and suppliers must continuously demonstrate reliability across diverse populations and imaging environments. Competitive intensity is also rising as specialized algorithms become integrated into larger enterprise-imaging, AI-orchestration and scanner-vendor ecosystems. Consolidation may increase access to distribution while simultaneously reducing the number of independent purchasing decisions available to smaller vendors. Data privacy requirements, cross-border cloud deployment rules, cybersecurity expectations and evolving AI regulation add further complexity. The market therefore favors companies that can combine validated algorithms with clinical integration, scalable deployment, regulatory execution and durable relationships with hospitals or pharmaceutical customers.Value Chain Analysis
The Neuroimaging Software value chain begins with medical imaging data, computational infrastructure, image-processing frameworks, anatomical atlases, clinically annotated datasets and algorithm-development capabilities. These inputs support the development of segmentation, registration, volumetric analysis, perfusion modeling, diffusion analysis, functional mapping, molecular imaging quantification and AI-based detection tools. The midstream layer consists of specialized software companies, medical-imaging OEMs, clinical AI developers, nuclear-medicine software providers, neurosurgical planning vendors and CNS imaging platforms. Products are commercialized through perpetual or term licenses, enterprise subscriptions, SaaS contracts, per-scan or usage-based models, OEM embedding arrangements and clinical-trial contracts.Value is created when raw imaging data are converted into quantitative measurements, biomarkers, workflow prioritization, treatment-planning information or longitudinal evidence that improves decision consistency and reduces manual analytical work. Downstream users include hospitals, imaging centers, neurology and neurosurgery departments, pharmaceutical and biotechnology companies, CROs and research institutions. Cost structures are dominated by software R&D, clinical validation, regulatory compliance, data acquisition and curation, cloud infrastructure, cybersecurity, integration, sales and implementation. As deployment moves toward recurring SaaS and enterprise models, scalable software economics become more important, but clinical support, integration and regulatory maintenance remain meaningful cost components.
Segment Insights
From a product-function perspective, the market contains several commercially meaningful segments rather than a single homogeneous software category. Acute stroke and neurovascular analysis is one of the most established clinical applications because software outputs can be integrated directly into time-sensitive emergency workflows. Advanced post-processing and visualization also represent an established installed-base segment through major imaging vendors. Quantitative brain MRI, neurodegenerative disease assessment and longitudinal biomarker analysis are gaining strategic importance as neurological treatment pathways increasingly require repeatable measurements rather than qualitative interpretation alone. MRI-related applications represent the broadest product coverage across the identified supplier universe, spanning structural volumetry, diffusion imaging, functional mapping, perfusion, multiple-sclerosis analysis and neuro-oncology.The fastest-evolving opportunity set is concentrated around quantitative and treatment-linked applications rather than basic image viewing. Automated brain segmentation, hippocampal and regional volumetry, cortical and lesion measurement, ARIA assessment and longitudinal change analysis are becoming increasingly differentiated commercial functions. CMS documentation recognizes multiple FDA-cleared products addressing automated labeling, visualization and volumetric quantification of brain MRI, as well as dedicated ARIA analysis, supporting the emergence of a more defined regulated quantitative-neuroimaging segment. Functional MRI, DTI, tractography, connectomics and molecular neuroimaging remain smaller but technically differentiated segments with strong relevance in neurosurgery, research and CNS drug development.
Downstream Market Opportunities
Hospitals and diagnostic imaging centers remain the primary commercial users of Neuroimaging Software, but the demand profile is widening beyond the radiology department. Stroke centers require rapid neurovascular triage and perfusion analysis, neurology services increasingly use quantitative MRI for neurodegenerative and demyelinating diseases, and neurosurgical teams require multimodal fusion, tractography and functional mapping for preoperative planning. Pharmaceutical and biotechnology companies represent an increasingly strategic downstream opportunity because CNS drug programs depend on standardized longitudinal imaging biomarkers, patient stratification and safety monitoring. This creates room for software suppliers that can bridge routine clinical imaging and research-grade quantitative analysis. Smaller hospitals and imaging networks also represent an underpenetrated opportunity as cloud-based deployment reduces the need for dedicated local workstations and specialist post-processing resources.Regional Insights
Europe has the largest concentration of identified independent specialist Neuroimaging Software suppliers, particularly in quantitative brain MRI, perfusion, nuclear medicine, functional imaging and neurodegenerative disease analysis. The region combines established medical-imaging technology clusters with a relatively broad base of smaller specialist developers. North America has a different competitive structure: major imaging and digital-health platforms coexist with commercially advanced stroke-AI, neurosurgical planning, quantitative imaging and research-software providers. The region remains particularly important for regulated clinical commercialization because FDA clearance, large hospital networks and pharmaceutical demand can support broader deployment of successful products. CMS activity around automated brain MRI quantification also highlights increasing attention to the clinical and reimbursement framework for quantitative neuroimaging.Asia-Pacific is becoming more strategically important but remains structurally fragmented. Japan combines global imaging OEMs with domestic neurological AI developers, while South Korea has developed a relatively dense cluster of specialist brain-imaging AI companies focused on volumetry, stroke, Parkinson’s disease, intracranial hemorrhage and cerebrovascular analysis. China has a growing medical-AI ecosystem, although the stricter product-evidence standard applied in this study results in a smaller Core Formal List than in Europe or North America. Taiwan and Australia contribute several niche vendors in diffusion MRI, brain metastasis analysis, perfusion and quantitative neuroimaging. The regional opportunity therefore lies less in simple geographic expansion and more in localization, regulatory approval, hospital integration and adaptation to country-specific clinical workflows.
Competitive Landscape Analysis
The Neuroimaging Software market has a layered competitive structure rather than a single group of directly comparable competitors. Major imaging OEMs compete through scanner installed bases, integrated workstations, enterprise-imaging relationships and global distribution, while independent specialists compete through deeper algorithms and clinical focus in stroke, brain volumetry, neurodegeneration, perfusion, molecular imaging, fMRI/DTI, neuro-oncology and neurosurgical planning. The study identifies 61 companies in the Core Formal List, demonstrating that the commercially relevant supplier base extends well beyond a small group of global imaging companies. Competitive consolidation is increasing as larger platforms acquire specialized software capabilities. GE HealthCare closed its acquisition of icometrix in 2025 to strengthen neurological MRI analysis, SyntheticMR acquired Combinostics to broaden quantitative neuroimaging capabilities, and RadNet acquired Gleamer in 2026 to expand DeepHealth’s clinical AI portfolio. These transactions point toward continued integration of specialist algorithms into broader imaging ecosystems, but highly differentiated areas such as ARIA quantification, connectomics, advanced perfusion, molecular imaging and functional brain mapping continue to provide defensible positions for focused vendors.Report Scope
LPI (LP Information)' newest research report, the “Neuroimaging Software Industry Forecast” looks at past sales and reviews total world Neuroimaging Software sales in 2025, providing a comprehensive analysis by region and market sector of projected Neuroimaging Software sales for 2026 through 2032. With Neuroimaging Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuroimaging Software industry.This Insight Report provides a comprehensive analysis of the global Neuroimaging Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neuroimaging Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neuroimaging Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuroimaging Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuroimaging Software.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuroimaging Software market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
- Advanced Post-processing and Visualization
- Quantitative Biomarkers and Volumetry
- AI Detection
- Molecular Neuroimaging Quantification
- Others
Segmentation by Deployment Model:
- On-premise
- Cloud-based
- Hybrid
Segmentation by Intended Use:
- Clinical Diagnostic or Decision Support
- Clinical Trial or Drug Development
- Research Use Only
- Others
Segmentation by Application:
- Stroke and Cerebrovascular Disease
- Neurodegenerative Disease and Multiple Sclerosis
- Neuro-oncology
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GE HealthCare
- Siemens Healthineers
- RapidAI
- Viz.ai
- Philips
- Brainlab
- Canon
- Fujifilm
- Brainomix
- Bruker
- Cortechs.ai
- RadNet
- Aidoc
- ConcertAI
- Qure.ai
- United Imaging Intelligence
- Shukun Technology
- Infervision
- Stryker
- Nicolab
- Avicenna.AI
- Synaptive Medical
- Quibim
- Surgical Theater
- mediaire
- Qynapse
- Thermo Fisher
- Hermes Medical Solutions
- Omniscient Neurotechnology
- IQ-AI
- Neurophet
- LPIXEL
- JLK
- Brainreader
- NordicNeuroLab
- VUNO
- Heuron
- Coreline Soft
- Cercare Medical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuroimaging Software Market Size (2021-2032)
2.1.2 Neuroimaging Software Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Neuroimaging Software by Country/Region (2021, 2025 & 2032)
2.2 Neuroimaging Software Segment by Type
2.2.1 Advanced Post-processing and Visualization
2.2.2 Quantitative Biomarkers and Volumetry
2.2.3 AI Detection
2.2.4 Molecular Neuroimaging Quantification
2.2.5 Others
2.2.6 Neuroimaging Software Market Size by Type
2.2.6.1 Neuroimaging Software Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Neuroimaging Software Market Size Market Share by Type (2021-2026)
2.3 Neuroimaging Software Segment by Deployment Model
2.3.1 On-premise
2.3.2 Cloud-based
2.3.3 Hybrid
2.3.4 Neuroimaging Software Market Size by Deployment Model
2.3.4.1 Neuroimaging Software Market Size CAGR by Deployment Model (2021 VS 2025 VS 2032)
2.3.4.2 Global Neuroimaging Software Market Size Market Share by Deployment Model (2021-2026)
2.4 Neuroimaging Software Segment by Intended Use
2.4.1 Clinical Diagnostic or Decision Support
2.4.2 Clinical Trial or Drug Development
2.4.3 Research Use Only
2.4.4 Others
2.4.5 Neuroimaging Software Market Size by Intended Use
2.4.5.1 Neuroimaging Software Market Size CAGR by Intended Use (2021 VS 2025 VS 2032)
2.4.5.2 Global Neuroimaging Software Market Size Market Share by Intended Use (2021-2026)
2.5 Neuroimaging Software Segment by Application
2.5.1 Stroke and Cerebrovascular Disease
2.5.2 Neurodegenerative Disease and Multiple Sclerosis
2.5.3 Neuro-oncology
2.5.4 Others
2.5.5 Neuroimaging Software Market Size by Application
2.5.5.1 Neuroimaging Software Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Neuroimaging Software Market Size Market Share by Application (2021-2026)
3 NEUROIMAGING SOFTWARE MARKET SIZE BY PLAYER
3.1 Neuroimaging Software Market Size Market Share by Player
3.1.1 Global Neuroimaging Software Revenue by Player (2021-2026)
3.1.2 Global Neuroimaging Software Revenue Market Share by Player (2021-2026)
3.2 Global Neuroimaging Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROIMAGING SOFTWARE BY REGION
4.1 Neuroimaging Software Market Size by Region (2021-2026)
4.2 Global Neuroimaging Software Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neuroimaging Software Market Size Growth (2021-2026)
4.4 APAC Neuroimaging Software Market Size Growth (2021-2026)
4.5 Europe Neuroimaging Software Market Size Growth (2021-2026)
4.6 Middle East & Africa Neuroimaging Software Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Neuroimaging Software Market Size by Country (2021-2026)
5.2 Americas Neuroimaging Software Market Size by Type (2021-2026)
5.3 Americas Neuroimaging Software Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuroimaging Software Market Size by Region (2021-2026)
6.2 APAC Neuroimaging Software Market Size by Type (2021-2026)
6.3 APAC Neuroimaging Software Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neuroimaging Software Market Size by Country (2021-2026)
7.2 Europe Neuroimaging Software Market Size by Type (2021-2026)
7.3 Europe Neuroimaging Software Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuroimaging Software by Region (2021-2026)
8.2 Middle East & Africa Neuroimaging Software Market Size by Type (2021-2026)
8.3 Middle East & Africa Neuroimaging Software Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROIMAGING SOFTWARE MARKET FORECAST
10.1 Global Neuroimaging Software Forecast by Region (2027-2032)
10.1.1 Global Neuroimaging Software Forecast by Region (2027-2032)
10.1.2 Americas Neuroimaging Software Forecast
10.1.3 APAC Neuroimaging Software Forecast
10.1.4 Europe Neuroimaging Software Forecast
10.1.5 Middle East & Africa Neuroimaging Software Forecast
10.2 Americas Neuroimaging Software Forecast by Country (2027-2032)
10.2.1 United States Market Neuroimaging Software Forecast
10.2.2 Canada Market Neuroimaging Software Forecast
10.2.3 Mexico Market Neuroimaging Software Forecast
10.2.4 Brazil Market Neuroimaging Software Forecast
10.3 APAC Neuroimaging Software Forecast by Region (2027-2032)
10.3.1 China Neuroimaging Software Market Forecast
10.3.2 Japan Market Neuroimaging Software Forecast
10.3.3 Korea Market Neuroimaging Software Forecast
10.3.4 Southeast Asia Market Neuroimaging Software Forecast
10.3.5 India Market Neuroimaging Software Forecast
10.3.6 Australia Market Neuroimaging Software Forecast
10.4 Europe Neuroimaging Software Forecast by Country (2027-2032)
10.4.1 Germany Market Neuroimaging Software Forecast
10.4.2 France Market Neuroimaging Software Forecast
10.4.3 UK Market Neuroimaging Software Forecast
10.4.4 Italy Market Neuroimaging Software Forecast
10.4.5 Russia Market Neuroimaging Software Forecast
10.5 Middle East & Africa Neuroimaging Software Forecast by Region (2027-2032)
10.5.1 Egypt Market Neuroimaging Software Forecast
10.5.2 South Africa Market Neuroimaging Software Forecast
10.5.3 Israel Market Neuroimaging Software Forecast
10.5.4 Turkey Market Neuroimaging Software Forecast
10.6 Global Neuroimaging Software Forecast by Type (2027-2032)
10.7 Global Neuroimaging Software Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Neuroimaging Software Forecast
11 KEY PLAYERS ANALYSIS
11.1 GE HealthCare
11.1.1 GE HealthCare Company Information
11.1.2 GE HealthCare Neuroimaging Software Product Offered
11.1.3 GE HealthCare Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 GE HealthCare Main Business Overview
11.1.5 GE HealthCare Latest Developments
11.2 Siemens Healthineers
11.2.1 Siemens Healthineers Company Information
11.2.2 Siemens Healthineers Neuroimaging Software Product Offered
11.2.3 Siemens Healthineers Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Siemens Healthineers Main Business Overview
11.2.5 Siemens Healthineers Latest Developments
11.3 RapidAI
11.3.1 RapidAI Company Information
11.3.2 RapidAI Neuroimaging Software Product Offered
11.3.3 RapidAI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 RapidAI Main Business Overview
11.3.5 RapidAI Latest Developments
11.4 Viz.ai
11.4.1 Viz.ai Company Information
11.4.2 Viz.ai Neuroimaging Software Product Offered
11.4.3 Viz.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Viz.ai Main Business Overview
11.4.5 Viz.ai Latest Developments
11.5 Philips
11.5.1 Philips Company Information
11.5.2 Philips Neuroimaging Software Product Offered
11.5.3 Philips Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Philips Main Business Overview
11.5.5 Philips Latest Developments
11.6 Brainlab
11.6.1 Brainlab Company Information
11.6.2 Brainlab Neuroimaging Software Product Offered
11.6.3 Brainlab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Brainlab Main Business Overview
11.6.5 Brainlab Latest Developments
11.7 Canon
11.7.1 Canon Company Information
11.7.2 Canon Neuroimaging Software Product Offered
11.7.3 Canon Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Canon Main Business Overview
11.7.5 Canon Latest Developments
11.8 Fujifilm
11.8.1 Fujifilm Company Information
11.8.2 Fujifilm Neuroimaging Software Product Offered
11.8.3 Fujifilm Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Fujifilm Main Business Overview
11.8.5 Fujifilm Latest Developments
11.9 Brainomix
11.9.1 Brainomix Company Information
11.9.2 Brainomix Neuroimaging Software Product Offered
11.9.3 Brainomix Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Brainomix Main Business Overview
11.9.5 Brainomix Latest Developments
11.10 Bruker
11.10.1 Bruker Company Information
11.10.2 Bruker Neuroimaging Software Product Offered
11.10.3 Bruker Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Bruker Main Business Overview
11.10.5 Bruker Latest Developments
11.11 Cortechs.ai
11.11.1 Cortechs.ai Company Information
11.11.2 Cortechs.ai Neuroimaging Software Product Offered
11.11.3 Cortechs.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cortechs.ai Main Business Overview
11.11.5 Cortechs.ai Latest Developments
11.12 RadNet
11.12.1 RadNet Company Information
11.12.2 RadNet Neuroimaging Software Product Offered
11.12.3 RadNet Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 RadNet Main Business Overview
11.12.5 RadNet Latest Developments
11.13 Aidoc
11.13.1 Aidoc Company Information
11.13.2 Aidoc Neuroimaging Software Product Offered
11.13.3 Aidoc Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Aidoc Main Business Overview
11.13.5 Aidoc Latest Developments
11.14 ConcertAI
11.14.1 ConcertAI Company Information
11.14.2 ConcertAI Neuroimaging Software Product Offered
11.14.3 ConcertAI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 ConcertAI Main Business Overview
11.14.5 ConcertAI Latest Developments
11.15 Qure.ai
11.15.1 Qure.ai Company Information
11.15.2 Qure.ai Neuroimaging Software Product Offered
11.15.3 Qure.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Qure.ai Main Business Overview
11.15.5 Qure.ai Latest Developments
11.16 United Imaging Intelligence
11.16.1 United Imaging Intelligence Company Information
11.16.2 United Imaging Intelligence Neuroimaging Software Product Offered
11.16.3 United Imaging Intelligence Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 United Imaging Intelligence Main Business Overview
11.16.5 United Imaging Intelligence Latest Developments
11.17 Shukun Technology
11.17.1 Shukun Technology Company Information
11.17.2 Shukun Technology Neuroimaging Software Product Offered
11.17.3 Shukun Technology Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Shukun Technology Main Business Overview
11.17.5 Shukun Technology Latest Developments
11.18 Infervision
11.18.1 Infervision Company Information
11.18.2 Infervision Neuroimaging Software Product Offered
11.18.3 Infervision Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Infervision Main Business Overview
11.18.5 Infervision Latest Developments
11.19 Stryker
11.19.1 Stryker Company Information
11.19.2 Stryker Neuroimaging Software Product Offered
11.19.3 Stryker Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Stryker Main Business Overview
11.19.5 Stryker Latest Developments
11.20 Nicolab
11.20.1 Nicolab Company Information
11.20.2 Nicolab Neuroimaging Software Product Offered
11.20.3 Nicolab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Nicolab Main Business Overview
11.20.5 Nicolab Latest Developments
11.21 Avicenna.AI
11.21.1 Avicenna.AI Company Information
11.21.2 Avicenna.AI Neuroimaging Software Product Offered
11.21.3 Avicenna.AI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Avicenna.AI Main Business Overview
11.21.5 Avicenna.AI Latest Developments
11.22 Synaptive Medical
11.22.1 Synaptive Medical Company Information
11.22.2 Synaptive Medical Neuroimaging Software Product Offered
11.22.3 Synaptive Medical Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Synaptive Medical Main Business Overview
11.22.5 Synaptive Medical Latest Developments
11.23 Quibim
11.23.1 Quibim Company Information
11.23.2 Quibim Neuroimaging Software Product Offered
11.23.3 Quibim Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Quibim Main Business Overview
11.23.5 Quibim Latest Developments
11.24 Surgical Theater
11.24.1 Surgical Theater Company Information
11.24.2 Surgical Theater Neuroimaging Software Product Offered
11.24.3 Surgical Theater Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Surgical Theater Main Business Overview
11.24.5 Surgical Theater Latest Developments
11.25 mediaire
11.25.1 mediaire Company Information
11.25.2 mediaire Neuroimaging Software Product Offered
11.25.3 mediaire Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 mediaire Main Business Overview
11.25.5 mediaire Latest Developments
11.26 Qynapse
11.26.1 Qynapse Company Information
11.26.2 Qynapse Neuroimaging Software Product Offered
11.26.3 Qynapse Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Qynapse Main Business Overview
11.26.5 Qynapse Latest Developments
11.27 Thermo Fisher
11.27.1 Thermo Fisher Company Information
11.27.2 Thermo Fisher Neuroimaging Software Product Offered
11.27.3 Thermo Fisher Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 Thermo Fisher Main Business Overview
11.27.5 Thermo Fisher Latest Developments
11.28 Hermes Medical Solutions
11.28.1 Hermes Medical Solutions Company Information
11.28.2 Hermes Medical Solutions Neuroimaging Software Product Offered
11.28.3 Hermes Medical Solutions Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 Hermes Medical Solutions Main Business Overview
11.28.5 Hermes Medical Solutions Latest Developments
11.29 Omniscient Neurotechnology
11.29.1 Omniscient Neurotechnology Company Information
11.29.2 Omniscient Neurotechnology Neuroimaging Software Product Offered
11.29.3 Omniscient Neurotechnology Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 Omniscient Neurotechnology Main Business Overview
11.29.5 Omniscient Neurotechnology Latest Developments
11.30 IQ-AI
11.30.1 IQ-AI Company Information
11.30.2 IQ-AI Neuroimaging Software Product Offered
11.30.3 IQ-AI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 IQ-AI Main Business Overview
11.30.5 IQ-AI Latest Developments
11.31 Neurophet
11.31.1 Neurophet Company Information
11.31.2 Neurophet Neuroimaging Software Product Offered
11.31.3 Neurophet Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 Neurophet Main Business Overview
11.31.5 Neurophet Latest Developments
11.32 LPIXEL
11.32.1 LPIXEL Company Information
11.32.2 LPIXEL Neuroimaging Software Product Offered
11.32.3 LPIXEL Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 LPIXEL Main Business Overview
11.32.5 LPIXEL Latest Developments
11.33 JLK
11.33.1 JLK Company Information
11.33.2 JLK Neuroimaging Software Product Offered
11.33.3 JLK Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.33.4 JLK Main Business Overview
11.33.5 JLK Latest Developments
11.34 Brainreader
11.34.1 Brainreader Company Information
11.34.2 Brainreader Neuroimaging Software Product Offered
11.34.3 Brainreader Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.34.4 Brainreader Main Business Overview
11.34.5 Brainreader Latest Developments
11.35 NordicNeuroLab
11.35.1 NordicNeuroLab Company Information
11.35.2 NordicNeuroLab Neuroimaging Software Product Offered
11.35.3 NordicNeuroLab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.35.4 NordicNeuroLab Main Business Overview
11.35.5 NordicNeuroLab Latest Developments
11.36 VUNO
11.36.1 VUNO Company Information
11.36.2 VUNO Neuroimaging Software Product Offered
11.36.3 VUNO Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.36.4 VUNO Main Business Overview
11.36.5 VUNO Latest Developments
11.37 Heuron
11.37.1 Heuron Company Information
11.37.2 Heuron Neuroimaging Software Product Offered
11.37.3 Heuron Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.37.4 Heuron Main Business Overview
11.37.5 Heuron Latest Developments
11.38 Coreline Soft
11.38.1 Coreline Soft Company Information
11.38.2 Coreline Soft Neuroimaging Software Product Offered
11.38.3 Coreline Soft Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.38.4 Coreline Soft Main Business Overview
11.38.5 Coreline Soft Latest Developments
11.39 Cercare Medical
11.39.1 Cercare Medical Company Information
11.39.2 Cercare Medical Neuroimaging Software Product Offered
11.39.3 Cercare Medical Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.39.4 Cercare Medical Main Business Overview
11.39.5 Cercare Medical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuroimaging Software Market Size (2021-2032)
2.1.2 Neuroimaging Software Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Neuroimaging Software by Country/Region (2021, 2025 & 2032)
2.2 Neuroimaging Software Segment by Type
2.2.1 Advanced Post-processing and Visualization
2.2.2 Quantitative Biomarkers and Volumetry
2.2.3 AI Detection
2.2.4 Molecular Neuroimaging Quantification
2.2.5 Others
2.2.6 Neuroimaging Software Market Size by Type
2.2.6.1 Neuroimaging Software Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Neuroimaging Software Market Size Market Share by Type (2021-2026)
2.3 Neuroimaging Software Segment by Deployment Model
2.3.1 On-premise
2.3.2 Cloud-based
2.3.3 Hybrid
2.3.4 Neuroimaging Software Market Size by Deployment Model
2.3.4.1 Neuroimaging Software Market Size CAGR by Deployment Model (2021 VS 2025 VS 2032)
2.3.4.2 Global Neuroimaging Software Market Size Market Share by Deployment Model (2021-2026)
2.4 Neuroimaging Software Segment by Intended Use
2.4.1 Clinical Diagnostic or Decision Support
2.4.2 Clinical Trial or Drug Development
2.4.3 Research Use Only
2.4.4 Others
2.4.5 Neuroimaging Software Market Size by Intended Use
2.4.5.1 Neuroimaging Software Market Size CAGR by Intended Use (2021 VS 2025 VS 2032)
2.4.5.2 Global Neuroimaging Software Market Size Market Share by Intended Use (2021-2026)
2.5 Neuroimaging Software Segment by Application
2.5.1 Stroke and Cerebrovascular Disease
2.5.2 Neurodegenerative Disease and Multiple Sclerosis
2.5.3 Neuro-oncology
2.5.4 Others
2.5.5 Neuroimaging Software Market Size by Application
2.5.5.1 Neuroimaging Software Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Neuroimaging Software Market Size Market Share by Application (2021-2026)
3 NEUROIMAGING SOFTWARE MARKET SIZE BY PLAYER
3.1 Neuroimaging Software Market Size Market Share by Player
3.1.1 Global Neuroimaging Software Revenue by Player (2021-2026)
3.1.2 Global Neuroimaging Software Revenue Market Share by Player (2021-2026)
3.2 Global Neuroimaging Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROIMAGING SOFTWARE BY REGION
4.1 Neuroimaging Software Market Size by Region (2021-2026)
4.2 Global Neuroimaging Software Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neuroimaging Software Market Size Growth (2021-2026)
4.4 APAC Neuroimaging Software Market Size Growth (2021-2026)
4.5 Europe Neuroimaging Software Market Size Growth (2021-2026)
4.6 Middle East & Africa Neuroimaging Software Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Neuroimaging Software Market Size by Country (2021-2026)
5.2 Americas Neuroimaging Software Market Size by Type (2021-2026)
5.3 Americas Neuroimaging Software Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuroimaging Software Market Size by Region (2021-2026)
6.2 APAC Neuroimaging Software Market Size by Type (2021-2026)
6.3 APAC Neuroimaging Software Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neuroimaging Software Market Size by Country (2021-2026)
7.2 Europe Neuroimaging Software Market Size by Type (2021-2026)
7.3 Europe Neuroimaging Software Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuroimaging Software by Region (2021-2026)
8.2 Middle East & Africa Neuroimaging Software Market Size by Type (2021-2026)
8.3 Middle East & Africa Neuroimaging Software Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROIMAGING SOFTWARE MARKET FORECAST
10.1 Global Neuroimaging Software Forecast by Region (2027-2032)
10.1.1 Global Neuroimaging Software Forecast by Region (2027-2032)
10.1.2 Americas Neuroimaging Software Forecast
10.1.3 APAC Neuroimaging Software Forecast
10.1.4 Europe Neuroimaging Software Forecast
10.1.5 Middle East & Africa Neuroimaging Software Forecast
10.2 Americas Neuroimaging Software Forecast by Country (2027-2032)
10.2.1 United States Market Neuroimaging Software Forecast
10.2.2 Canada Market Neuroimaging Software Forecast
10.2.3 Mexico Market Neuroimaging Software Forecast
10.2.4 Brazil Market Neuroimaging Software Forecast
10.3 APAC Neuroimaging Software Forecast by Region (2027-2032)
10.3.1 China Neuroimaging Software Market Forecast
10.3.2 Japan Market Neuroimaging Software Forecast
10.3.3 Korea Market Neuroimaging Software Forecast
10.3.4 Southeast Asia Market Neuroimaging Software Forecast
10.3.5 India Market Neuroimaging Software Forecast
10.3.6 Australia Market Neuroimaging Software Forecast
10.4 Europe Neuroimaging Software Forecast by Country (2027-2032)
10.4.1 Germany Market Neuroimaging Software Forecast
10.4.2 France Market Neuroimaging Software Forecast
10.4.3 UK Market Neuroimaging Software Forecast
10.4.4 Italy Market Neuroimaging Software Forecast
10.4.5 Russia Market Neuroimaging Software Forecast
10.5 Middle East & Africa Neuroimaging Software Forecast by Region (2027-2032)
10.5.1 Egypt Market Neuroimaging Software Forecast
10.5.2 South Africa Market Neuroimaging Software Forecast
10.5.3 Israel Market Neuroimaging Software Forecast
10.5.4 Turkey Market Neuroimaging Software Forecast
10.6 Global Neuroimaging Software Forecast by Type (2027-2032)
10.7 Global Neuroimaging Software Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Neuroimaging Software Forecast
11 KEY PLAYERS ANALYSIS
11.1 GE HealthCare
11.1.1 GE HealthCare Company Information
11.1.2 GE HealthCare Neuroimaging Software Product Offered
11.1.3 GE HealthCare Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 GE HealthCare Main Business Overview
11.1.5 GE HealthCare Latest Developments
11.2 Siemens Healthineers
11.2.1 Siemens Healthineers Company Information
11.2.2 Siemens Healthineers Neuroimaging Software Product Offered
11.2.3 Siemens Healthineers Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Siemens Healthineers Main Business Overview
11.2.5 Siemens Healthineers Latest Developments
11.3 RapidAI
11.3.1 RapidAI Company Information
11.3.2 RapidAI Neuroimaging Software Product Offered
11.3.3 RapidAI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 RapidAI Main Business Overview
11.3.5 RapidAI Latest Developments
11.4 Viz.ai
11.4.1 Viz.ai Company Information
11.4.2 Viz.ai Neuroimaging Software Product Offered
11.4.3 Viz.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Viz.ai Main Business Overview
11.4.5 Viz.ai Latest Developments
11.5 Philips
11.5.1 Philips Company Information
11.5.2 Philips Neuroimaging Software Product Offered
11.5.3 Philips Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Philips Main Business Overview
11.5.5 Philips Latest Developments
11.6 Brainlab
11.6.1 Brainlab Company Information
11.6.2 Brainlab Neuroimaging Software Product Offered
11.6.3 Brainlab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Brainlab Main Business Overview
11.6.5 Brainlab Latest Developments
11.7 Canon
11.7.1 Canon Company Information
11.7.2 Canon Neuroimaging Software Product Offered
11.7.3 Canon Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Canon Main Business Overview
11.7.5 Canon Latest Developments
11.8 Fujifilm
11.8.1 Fujifilm Company Information
11.8.2 Fujifilm Neuroimaging Software Product Offered
11.8.3 Fujifilm Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Fujifilm Main Business Overview
11.8.5 Fujifilm Latest Developments
11.9 Brainomix
11.9.1 Brainomix Company Information
11.9.2 Brainomix Neuroimaging Software Product Offered
11.9.3 Brainomix Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Brainomix Main Business Overview
11.9.5 Brainomix Latest Developments
11.10 Bruker
11.10.1 Bruker Company Information
11.10.2 Bruker Neuroimaging Software Product Offered
11.10.3 Bruker Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Bruker Main Business Overview
11.10.5 Bruker Latest Developments
11.11 Cortechs.ai
11.11.1 Cortechs.ai Company Information
11.11.2 Cortechs.ai Neuroimaging Software Product Offered
11.11.3 Cortechs.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cortechs.ai Main Business Overview
11.11.5 Cortechs.ai Latest Developments
11.12 RadNet
11.12.1 RadNet Company Information
11.12.2 RadNet Neuroimaging Software Product Offered
11.12.3 RadNet Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 RadNet Main Business Overview
11.12.5 RadNet Latest Developments
11.13 Aidoc
11.13.1 Aidoc Company Information
11.13.2 Aidoc Neuroimaging Software Product Offered
11.13.3 Aidoc Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Aidoc Main Business Overview
11.13.5 Aidoc Latest Developments
11.14 ConcertAI
11.14.1 ConcertAI Company Information
11.14.2 ConcertAI Neuroimaging Software Product Offered
11.14.3 ConcertAI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 ConcertAI Main Business Overview
11.14.5 ConcertAI Latest Developments
11.15 Qure.ai
11.15.1 Qure.ai Company Information
11.15.2 Qure.ai Neuroimaging Software Product Offered
11.15.3 Qure.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Qure.ai Main Business Overview
11.15.5 Qure.ai Latest Developments
11.16 United Imaging Intelligence
11.16.1 United Imaging Intelligence Company Information
11.16.2 United Imaging Intelligence Neuroimaging Software Product Offered
11.16.3 United Imaging Intelligence Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 United Imaging Intelligence Main Business Overview
11.16.5 United Imaging Intelligence Latest Developments
11.17 Shukun Technology
11.17.1 Shukun Technology Company Information
11.17.2 Shukun Technology Neuroimaging Software Product Offered
11.17.3 Shukun Technology Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Shukun Technology Main Business Overview
11.17.5 Shukun Technology Latest Developments
11.18 Infervision
11.18.1 Infervision Company Information
11.18.2 Infervision Neuroimaging Software Product Offered
11.18.3 Infervision Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Infervision Main Business Overview
11.18.5 Infervision Latest Developments
11.19 Stryker
11.19.1 Stryker Company Information
11.19.2 Stryker Neuroimaging Software Product Offered
11.19.3 Stryker Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Stryker Main Business Overview
11.19.5 Stryker Latest Developments
11.20 Nicolab
11.20.1 Nicolab Company Information
11.20.2 Nicolab Neuroimaging Software Product Offered
11.20.3 Nicolab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Nicolab Main Business Overview
11.20.5 Nicolab Latest Developments
11.21 Avicenna.AI
11.21.1 Avicenna.AI Company Information
11.21.2 Avicenna.AI Neuroimaging Software Product Offered
11.21.3 Avicenna.AI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Avicenna.AI Main Business Overview
11.21.5 Avicenna.AI Latest Developments
11.22 Synaptive Medical
11.22.1 Synaptive Medical Company Information
11.22.2 Synaptive Medical Neuroimaging Software Product Offered
11.22.3 Synaptive Medical Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Synaptive Medical Main Business Overview
11.22.5 Synaptive Medical Latest Developments
11.23 Quibim
11.23.1 Quibim Company Information
11.23.2 Quibim Neuroimaging Software Product Offered
11.23.3 Quibim Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Quibim Main Business Overview
11.23.5 Quibim Latest Developments
11.24 Surgical Theater
11.24.1 Surgical Theater Company Information
11.24.2 Surgical Theater Neuroimaging Software Product Offered
11.24.3 Surgical Theater Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Surgical Theater Main Business Overview
11.24.5 Surgical Theater Latest Developments
11.25 mediaire
11.25.1 mediaire Company Information
11.25.2 mediaire Neuroimaging Software Product Offered
11.25.3 mediaire Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 mediaire Main Business Overview
11.25.5 mediaire Latest Developments
11.26 Qynapse
11.26.1 Qynapse Company Information
11.26.2 Qynapse Neuroimaging Software Product Offered
11.26.3 Qynapse Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Qynapse Main Business Overview
11.26.5 Qynapse Latest Developments
11.27 Thermo Fisher
11.27.1 Thermo Fisher Company Information
11.27.2 Thermo Fisher Neuroimaging Software Product Offered
11.27.3 Thermo Fisher Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 Thermo Fisher Main Business Overview
11.27.5 Thermo Fisher Latest Developments
11.28 Hermes Medical Solutions
11.28.1 Hermes Medical Solutions Company Information
11.28.2 Hermes Medical Solutions Neuroimaging Software Product Offered
11.28.3 Hermes Medical Solutions Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 Hermes Medical Solutions Main Business Overview
11.28.5 Hermes Medical Solutions Latest Developments
11.29 Omniscient Neurotechnology
11.29.1 Omniscient Neurotechnology Company Information
11.29.2 Omniscient Neurotechnology Neuroimaging Software Product Offered
11.29.3 Omniscient Neurotechnology Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 Omniscient Neurotechnology Main Business Overview
11.29.5 Omniscient Neurotechnology Latest Developments
11.30 IQ-AI
11.30.1 IQ-AI Company Information
11.30.2 IQ-AI Neuroimaging Software Product Offered
11.30.3 IQ-AI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 IQ-AI Main Business Overview
11.30.5 IQ-AI Latest Developments
11.31 Neurophet
11.31.1 Neurophet Company Information
11.31.2 Neurophet Neuroimaging Software Product Offered
11.31.3 Neurophet Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 Neurophet Main Business Overview
11.31.5 Neurophet Latest Developments
11.32 LPIXEL
11.32.1 LPIXEL Company Information
11.32.2 LPIXEL Neuroimaging Software Product Offered
11.32.3 LPIXEL Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 LPIXEL Main Business Overview
11.32.5 LPIXEL Latest Developments
11.33 JLK
11.33.1 JLK Company Information
11.33.2 JLK Neuroimaging Software Product Offered
11.33.3 JLK Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.33.4 JLK Main Business Overview
11.33.5 JLK Latest Developments
11.34 Brainreader
11.34.1 Brainreader Company Information
11.34.2 Brainreader Neuroimaging Software Product Offered
11.34.3 Brainreader Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.34.4 Brainreader Main Business Overview
11.34.5 Brainreader Latest Developments
11.35 NordicNeuroLab
11.35.1 NordicNeuroLab Company Information
11.35.2 NordicNeuroLab Neuroimaging Software Product Offered
11.35.3 NordicNeuroLab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.35.4 NordicNeuroLab Main Business Overview
11.35.5 NordicNeuroLab Latest Developments
11.36 VUNO
11.36.1 VUNO Company Information
11.36.2 VUNO Neuroimaging Software Product Offered
11.36.3 VUNO Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.36.4 VUNO Main Business Overview
11.36.5 VUNO Latest Developments
11.37 Heuron
11.37.1 Heuron Company Information
11.37.2 Heuron Neuroimaging Software Product Offered
11.37.3 Heuron Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.37.4 Heuron Main Business Overview
11.37.5 Heuron Latest Developments
11.38 Coreline Soft
11.38.1 Coreline Soft Company Information
11.38.2 Coreline Soft Neuroimaging Software Product Offered
11.38.3 Coreline Soft Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.38.4 Coreline Soft Main Business Overview
11.38.5 Coreline Soft Latest Developments
11.39 Cercare Medical
11.39.1 Cercare Medical Company Information
11.39.2 Cercare Medical Neuroimaging Software Product Offered
11.39.3 Cercare Medical Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
11.39.4 Cercare Medical Main Business Overview
11.39.5 Cercare Medical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neuroimaging Software Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Neuroimaging Software Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Advanced Post-processing and Visualization
Table 4. Major Players of Quantitative Biomarkers and Volumetry
Table 5. Major Players of AI Detection
Table 6. Major Players of Molecular Neuroimaging Quantification
Table 7. Major Players of Others
Table 8. Neuroimaging Software Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Neuroimaging Software Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Neuroimaging Software Market Size Market Share by Type (2021-2026)
Table 11. Major Players of On-premise
Table 12. Major Players of Cloud-based
Table 13. Major Players of Hybrid
Table 14. Neuroimaging Software Market Size CAGR by Deployment Model (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global Neuroimaging Software Market Size by Deployment Model (2021-2026) & ($ millions)
Table 16. Global Neuroimaging Software Market Size Market Share by Deployment Model (2021-2026)
Table 17. Major Players of Clinical Diagnostic or Decision Support
Table 18. Major Players of Clinical Trial or Drug Development
Table 19. Major Players of Research Use Only
Table 20. Major Players of Others
Table 21. Neuroimaging Software Market Size CAGR by Intended Use (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Neuroimaging Software Market Size by Intended Use (2021-2026) & ($ millions)
Table 23. Global Neuroimaging Software Market Size Market Share by Intended Use (2021-2026)
Table 24. Neuroimaging Software Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Neuroimaging Software Market Size by Application (2021-2026) & ($ millions)
Table 26. Global Neuroimaging Software Market Size Market Share by Application (2021-2026)
Table 27. Global Neuroimaging Software Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Neuroimaging Software Revenue Market Share by Player (2021-2026)
Table 29. Neuroimaging Software Key Players Head office and Products Offered
Table 30. Neuroimaging Software Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Neuroimaging Software Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Neuroimaging Software Market Size Market Share by Region (2021-2026)
Table 35. Global Neuroimaging Software Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Neuroimaging Software Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Neuroimaging Software Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Neuroimaging Software Market Size Market Share by Country (2021-2026)
Table 39. Americas Neuroimaging Software Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Neuroimaging Software Market Size Market Share by Type (2021-2026)
Table 41. Americas Neuroimaging Software Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas Neuroimaging Software Market Size Market Share by Application (2021-2026)
Table 43. APAC Neuroimaging Software Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Neuroimaging Software Market Size Market Share by Region (2021-2026)
Table 45. APAC Neuroimaging Software Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Neuroimaging Software Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe Neuroimaging Software Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Neuroimaging Software Market Size Market Share by Country (2021-2026)
Table 49. Europe Neuroimaging Software Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Neuroimaging Software Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa Neuroimaging Software Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Neuroimaging Software Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Neuroimaging Software Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Neuroimaging Software
Table 55. Key Market Challenges & Risks of Neuroimaging Software
Table 56. Key Industry Trends of Neuroimaging Software
Table 57. Global Neuroimaging Software Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Neuroimaging Software Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Neuroimaging Software Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Neuroimaging Software Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. GE HealthCare Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 62. GE HealthCare Neuroimaging Software Product Offered
Table 63. GE HealthCare Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. GE HealthCare Main Business
Table 65. GE HealthCare Latest Developments
Table 66. Siemens Healthineers Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 67. Siemens Healthineers Neuroimaging Software Product Offered
Table 68. Siemens Healthineers Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Siemens Healthineers Main Business
Table 70. Siemens Healthineers Latest Developments
Table 71. RapidAI Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 72. RapidAI Neuroimaging Software Product Offered
Table 73. RapidAI Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. RapidAI Main Business
Table 75. RapidAI Latest Developments
Table 76. Viz.ai Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 77. Viz.ai Neuroimaging Software Product Offered
Table 78. Viz.ai Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Viz.ai Main Business
Table 80. Viz.ai Latest Developments
Table 81. Philips Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 82. Philips Neuroimaging Software Product Offered
Table 83. Philips Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Philips Main Business
Table 85. Philips Latest Developments
Table 86. Brainlab Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 87. Brainlab Neuroimaging Software Product Offered
Table 88. Brainlab Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Brainlab Main Business
Table 90. Brainlab Latest Developments
Table 91. Canon Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 92. Canon Neuroimaging Software Product Offered
Table 93. Canon Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Canon Main Business
Table 95. Canon Latest Developments
Table 96. Fujifilm Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 97. Fujifilm Neuroimaging Software Product Offered
Table 98. Fujifilm Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Fujifilm Main Business
Table 100. Fujifilm Latest Developments
Table 101. Brainomix Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 102. Brainomix Neuroimaging Software Product Offered
Table 103. Brainomix Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Brainomix Main Business
Table 105. Brainomix Latest Developments
Table 106. Bruker Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 107. Bruker Neuroimaging Software Product Offered
Table 108. Bruker Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Bruker Main Business
Table 110. Bruker Latest Developments
Table 111. Cortechs.ai Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 112. Cortechs.ai Neuroimaging Software Product Offered
Table 113. Cortechs.ai Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Cortechs.ai Main Business
Table 115. Cortechs.ai Latest Developments
Table 116. RadNet Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 117. RadNet Neuroimaging Software Product Offered
Table 118. RadNet Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. RadNet Main Business
Table 120. RadNet Latest Developments
Table 121. Aidoc Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 122. Aidoc Neuroimaging Software Product Offered
Table 123. Aidoc Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Aidoc Main Business
Table 125. Aidoc Latest Developments
Table 126. ConcertAI Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 127. ConcertAI Neuroimaging Software Product Offered
Table 128. ConcertAI Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. ConcertAI Main Business
Table 130. ConcertAI Latest Developments
Table 131. Qure.ai Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 132. Qure.ai Neuroimaging Software Product Offered
Table 133. Qure.ai Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Qure.ai Main Business
Table 135. Qure.ai Latest Developments
Table 136. United Imaging Intelligence Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 137. United Imaging Intelligence Neuroimaging Software Product Offered
Table 138. United Imaging Intelligence Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. United Imaging Intelligence Main Business
Table 140. United Imaging Intelligence Latest Developments
Table 141. Shukun Technology Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 142. Shukun Technology Neuroimaging Software Product Offered
Table 143. Shukun Technology Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Shukun Technology Main Business
Table 145. Shukun Technology Latest Developments
Table 146. Infervision Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 147. Infervision Neuroimaging Software Product Offered
Table 148. Infervision Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. Infervision Main Business
Table 150. Infervision Latest Developments
Table 151. Stryker Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 152. Stryker Neuroimaging Software Product Offered
Table 153. Stryker Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 154. Stryker Main Business
Table 155. Stryker Latest Developments
Table 156. Nicolab Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 157. Nicolab Neuroimaging Software Product Offered
Table 158. Nicolab Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 159. Nicolab Main Business
Table 160. Nicolab Latest Developments
Table 161. Avicenna.AI Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 162. Avicenna.AI Neuroimaging Software Product Offered
Table 163. Avicenna.AI Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 164. Avicenna.AI Main Business
Table 165. Avicenna.AI Latest Developments
Table 166. Synaptive Medical Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 167. Synaptive Medical Neuroimaging Software Product Offered
Table 168. Synaptive Medical Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 169. Synaptive Medical Main Business
Table 170. Synaptive Medical Latest Developments
Table 171. Quibim Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 172. Quibim Neuroimaging Software Product Offered
Table 173. Quibim Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 174. Quibim Main Business
Table 175. Quibim Latest Developments
Table 176. Surgical Theater Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 177. Surgical Theater Neuroimaging Software Product Offered
Table 178. Surgical Theater Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 179. Surgical Theater Main Business
Table 180. Surgical Theater Latest Developments
Table 181. mediaire Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 182. mediaire Neuroimaging Software Product Offered
Table 183. mediaire Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 184. mediaire Main Business
Table 185. mediaire Latest Developments
Table 186. Qynapse Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 187. Qynapse Neuroimaging Software Product Offered
Table 188. Qynapse Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 189. Qynapse Main Business
Table 190. Qynapse Latest Developments
Table 191. Thermo Fisher Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 192. Thermo Fisher Neuroimaging Software Product Offered
Table 193. Thermo Fisher Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 194. Thermo Fisher Main Business
Table 195. Thermo Fisher Latest Developments
Table 196. Hermes Medical Solutions Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 197. Hermes Medical Solutions Neuroimaging Software Product Offered
Table 198. Hermes Medical Solutions Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 199. Hermes Medical Solutions Main Business
Table 200. Hermes Medical Solutions Latest Developments
Table 201. Omniscient Neurotechnology Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 202. Omniscient Neurotechnology Neuroimaging Software Product Offered
Table 203. Omniscient Neurotechnology Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 204. Omniscient Neurotechnology Main Business
Table 205. Omniscient Neurotechnology Latest Developments
Table 206. IQ-AI Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 207. IQ-AI Neuroimaging Software Product Offered
Table 208. IQ-AI Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 209. IQ-AI Main Business
Table 210. IQ-AI Latest Developments
Table 211. Neurophet Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 212. Neurophet Neuroimaging Software Product Offered
Table 213. Neurophet Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 214. Neurophet Main Business
Table 215. Neurophet Latest Developments
Table 216. LPIXEL Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 217. LPIXEL Neuroimaging Software Product Offered
Table 218. LPIXEL Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 219. LPIXEL Main Business
Table 220. LPIXEL Latest Developments
Table 221. JLK Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 222. JLK Neuroimaging Software Product Offered
Table 223. JLK Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 224. JLK Main Business
Table 225. JLK Latest Developments
Table 226. Brainreader Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 227. Brainreader Neuroimaging Software Product Offered
Table 228. Brainreader Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 229. Brainreader Main Business
Table 230. Brainreader Latest Developments
Table 231. NordicNeuroLab Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 232. NordicNeuroLab Neuroimaging Software Product Offered
Table 233. NordicNeuroLab Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 234. NordicNeuroLab Main Business
Table 235. NordicNeuroLab Latest Developments
Table 236. VUNO Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 237. VUNO Neuroimaging Software Product Offered
Table 238. VUNO Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 239. VUNO Main Business
Table 240. VUNO Latest Developments
Table 241. Heuron Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 242. Heuron Neuroimaging Software Product Offered
Table 243. Heuron Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 244. Heuron Main Business
Table 245. Heuron Latest Developments
Table 246. Coreline Soft Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 247. Coreline Soft Neuroimaging Software Product Offered
Table 248. Coreline Soft Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 249. Coreline Soft Main Business
Table 250. Coreline Soft Latest Developments
Table 251. Cercare Medical Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 252. Cercare Medical Neuroimaging Software Product Offered
Table 253. Cercare Medical Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 254. Cercare Medical Main Business
Table 255. Cercare Medical Latest Developments
Table 1. Neuroimaging Software Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Neuroimaging Software Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Advanced Post-processing and Visualization
Table 4. Major Players of Quantitative Biomarkers and Volumetry
Table 5. Major Players of AI Detection
Table 6. Major Players of Molecular Neuroimaging Quantification
Table 7. Major Players of Others
Table 8. Neuroimaging Software Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Neuroimaging Software Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Neuroimaging Software Market Size Market Share by Type (2021-2026)
Table 11. Major Players of On-premise
Table 12. Major Players of Cloud-based
Table 13. Major Players of Hybrid
Table 14. Neuroimaging Software Market Size CAGR by Deployment Model (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global Neuroimaging Software Market Size by Deployment Model (2021-2026) & ($ millions)
Table 16. Global Neuroimaging Software Market Size Market Share by Deployment Model (2021-2026)
Table 17. Major Players of Clinical Diagnostic or Decision Support
Table 18. Major Players of Clinical Trial or Drug Development
Table 19. Major Players of Research Use Only
Table 20. Major Players of Others
Table 21. Neuroimaging Software Market Size CAGR by Intended Use (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Neuroimaging Software Market Size by Intended Use (2021-2026) & ($ millions)
Table 23. Global Neuroimaging Software Market Size Market Share by Intended Use (2021-2026)
Table 24. Neuroimaging Software Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Neuroimaging Software Market Size by Application (2021-2026) & ($ millions)
Table 26. Global Neuroimaging Software Market Size Market Share by Application (2021-2026)
Table 27. Global Neuroimaging Software Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Neuroimaging Software Revenue Market Share by Player (2021-2026)
Table 29. Neuroimaging Software Key Players Head office and Products Offered
Table 30. Neuroimaging Software Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Neuroimaging Software Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Neuroimaging Software Market Size Market Share by Region (2021-2026)
Table 35. Global Neuroimaging Software Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Neuroimaging Software Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Neuroimaging Software Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Neuroimaging Software Market Size Market Share by Country (2021-2026)
Table 39. Americas Neuroimaging Software Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Neuroimaging Software Market Size Market Share by Type (2021-2026)
Table 41. Americas Neuroimaging Software Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas Neuroimaging Software Market Size Market Share by Application (2021-2026)
Table 43. APAC Neuroimaging Software Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Neuroimaging Software Market Size Market Share by Region (2021-2026)
Table 45. APAC Neuroimaging Software Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Neuroimaging Software Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe Neuroimaging Software Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Neuroimaging Software Market Size Market Share by Country (2021-2026)
Table 49. Europe Neuroimaging Software Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Neuroimaging Software Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa Neuroimaging Software Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Neuroimaging Software Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Neuroimaging Software Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Neuroimaging Software
Table 55. Key Market Challenges & Risks of Neuroimaging Software
Table 56. Key Industry Trends of Neuroimaging Software
Table 57. Global Neuroimaging Software Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Neuroimaging Software Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Neuroimaging Software Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Neuroimaging Software Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. GE HealthCare Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 62. GE HealthCare Neuroimaging Software Product Offered
Table 63. GE HealthCare Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. GE HealthCare Main Business
Table 65. GE HealthCare Latest Developments
Table 66. Siemens Healthineers Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 67. Siemens Healthineers Neuroimaging Software Product Offered
Table 68. Siemens Healthineers Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Siemens Healthineers Main Business
Table 70. Siemens Healthineers Latest Developments
Table 71. RapidAI Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 72. RapidAI Neuroimaging Software Product Offered
Table 73. RapidAI Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. RapidAI Main Business
Table 75. RapidAI Latest Developments
Table 76. Viz.ai Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 77. Viz.ai Neuroimaging Software Product Offered
Table 78. Viz.ai Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Viz.ai Main Business
Table 80. Viz.ai Latest Developments
Table 81. Philips Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 82. Philips Neuroimaging Software Product Offered
Table 83. Philips Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Philips Main Business
Table 85. Philips Latest Developments
Table 86. Brainlab Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 87. Brainlab Neuroimaging Software Product Offered
Table 88. Brainlab Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Brainlab Main Business
Table 90. Brainlab Latest Developments
Table 91. Canon Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 92. Canon Neuroimaging Software Product Offered
Table 93. Canon Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Canon Main Business
Table 95. Canon Latest Developments
Table 96. Fujifilm Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 97. Fujifilm Neuroimaging Software Product Offered
Table 98. Fujifilm Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Fujifilm Main Business
Table 100. Fujifilm Latest Developments
Table 101. Brainomix Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 102. Brainomix Neuroimaging Software Product Offered
Table 103. Brainomix Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Brainomix Main Business
Table 105. Brainomix Latest Developments
Table 106. Bruker Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 107. Bruker Neuroimaging Software Product Offered
Table 108. Bruker Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Bruker Main Business
Table 110. Bruker Latest Developments
Table 111. Cortechs.ai Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 112. Cortechs.ai Neuroimaging Software Product Offered
Table 113. Cortechs.ai Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Cortechs.ai Main Business
Table 115. Cortechs.ai Latest Developments
Table 116. RadNet Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 117. RadNet Neuroimaging Software Product Offered
Table 118. RadNet Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. RadNet Main Business
Table 120. RadNet Latest Developments
Table 121. Aidoc Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 122. Aidoc Neuroimaging Software Product Offered
Table 123. Aidoc Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Aidoc Main Business
Table 125. Aidoc Latest Developments
Table 126. ConcertAI Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 127. ConcertAI Neuroimaging Software Product Offered
Table 128. ConcertAI Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. ConcertAI Main Business
Table 130. ConcertAI Latest Developments
Table 131. Qure.ai Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 132. Qure.ai Neuroimaging Software Product Offered
Table 133. Qure.ai Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Qure.ai Main Business
Table 135. Qure.ai Latest Developments
Table 136. United Imaging Intelligence Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 137. United Imaging Intelligence Neuroimaging Software Product Offered
Table 138. United Imaging Intelligence Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. United Imaging Intelligence Main Business
Table 140. United Imaging Intelligence Latest Developments
Table 141. Shukun Technology Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 142. Shukun Technology Neuroimaging Software Product Offered
Table 143. Shukun Technology Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Shukun Technology Main Business
Table 145. Shukun Technology Latest Developments
Table 146. Infervision Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 147. Infervision Neuroimaging Software Product Offered
Table 148. Infervision Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. Infervision Main Business
Table 150. Infervision Latest Developments
Table 151. Stryker Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 152. Stryker Neuroimaging Software Product Offered
Table 153. Stryker Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 154. Stryker Main Business
Table 155. Stryker Latest Developments
Table 156. Nicolab Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 157. Nicolab Neuroimaging Software Product Offered
Table 158. Nicolab Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 159. Nicolab Main Business
Table 160. Nicolab Latest Developments
Table 161. Avicenna.AI Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 162. Avicenna.AI Neuroimaging Software Product Offered
Table 163. Avicenna.AI Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 164. Avicenna.AI Main Business
Table 165. Avicenna.AI Latest Developments
Table 166. Synaptive Medical Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 167. Synaptive Medical Neuroimaging Software Product Offered
Table 168. Synaptive Medical Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 169. Synaptive Medical Main Business
Table 170. Synaptive Medical Latest Developments
Table 171. Quibim Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 172. Quibim Neuroimaging Software Product Offered
Table 173. Quibim Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 174. Quibim Main Business
Table 175. Quibim Latest Developments
Table 176. Surgical Theater Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 177. Surgical Theater Neuroimaging Software Product Offered
Table 178. Surgical Theater Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 179. Surgical Theater Main Business
Table 180. Surgical Theater Latest Developments
Table 181. mediaire Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 182. mediaire Neuroimaging Software Product Offered
Table 183. mediaire Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 184. mediaire Main Business
Table 185. mediaire Latest Developments
Table 186. Qynapse Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 187. Qynapse Neuroimaging Software Product Offered
Table 188. Qynapse Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 189. Qynapse Main Business
Table 190. Qynapse Latest Developments
Table 191. Thermo Fisher Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 192. Thermo Fisher Neuroimaging Software Product Offered
Table 193. Thermo Fisher Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 194. Thermo Fisher Main Business
Table 195. Thermo Fisher Latest Developments
Table 196. Hermes Medical Solutions Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 197. Hermes Medical Solutions Neuroimaging Software Product Offered
Table 198. Hermes Medical Solutions Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 199. Hermes Medical Solutions Main Business
Table 200. Hermes Medical Solutions Latest Developments
Table 201. Omniscient Neurotechnology Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 202. Omniscient Neurotechnology Neuroimaging Software Product Offered
Table 203. Omniscient Neurotechnology Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 204. Omniscient Neurotechnology Main Business
Table 205. Omniscient Neurotechnology Latest Developments
Table 206. IQ-AI Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 207. IQ-AI Neuroimaging Software Product Offered
Table 208. IQ-AI Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 209. IQ-AI Main Business
Table 210. IQ-AI Latest Developments
Table 211. Neurophet Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 212. Neurophet Neuroimaging Software Product Offered
Table 213. Neurophet Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 214. Neurophet Main Business
Table 215. Neurophet Latest Developments
Table 216. LPIXEL Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 217. LPIXEL Neuroimaging Software Product Offered
Table 218. LPIXEL Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 219. LPIXEL Main Business
Table 220. LPIXEL Latest Developments
Table 221. JLK Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 222. JLK Neuroimaging Software Product Offered
Table 223. JLK Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 224. JLK Main Business
Table 225. JLK Latest Developments
Table 226. Brainreader Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 227. Brainreader Neuroimaging Software Product Offered
Table 228. Brainreader Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 229. Brainreader Main Business
Table 230. Brainreader Latest Developments
Table 231. NordicNeuroLab Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 232. NordicNeuroLab Neuroimaging Software Product Offered
Table 233. NordicNeuroLab Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 234. NordicNeuroLab Main Business
Table 235. NordicNeuroLab Latest Developments
Table 236. VUNO Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 237. VUNO Neuroimaging Software Product Offered
Table 238. VUNO Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 239. VUNO Main Business
Table 240. VUNO Latest Developments
Table 241. Heuron Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 242. Heuron Neuroimaging Software Product Offered
Table 243. Heuron Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 244. Heuron Main Business
Table 245. Heuron Latest Developments
Table 246. Coreline Soft Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 247. Coreline Soft Neuroimaging Software Product Offered
Table 248. Coreline Soft Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 249. Coreline Soft Main Business
Table 250. Coreline Soft Latest Developments
Table 251. Cercare Medical Details, Company Type, Neuroimaging Software Area Served and Its Competitors
Table 252. Cercare Medical Neuroimaging Software Product Offered
Table 253. Cercare Medical Neuroimaging Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 254. Cercare Medical Main Business
Table 255. Cercare Medical Latest Developments
LIST OF FIGURES
Figure 1. Neuroimaging Software Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuroimaging Software Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Neuroimaging Software Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Neuroimaging Software Sales Market Share by Country/Region (2025)
Figure 8. Neuroimaging Software Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Neuroimaging Software Market Size Market Share by Type in 2025
Figure 10. Global Neuroimaging Software Market Size Market Share by Deployment Model in 2025
Figure 11. Global Neuroimaging Software Market Size Market Share by Intended Use in 2025
Figure 12. Neuroimaging Software in Stroke and Cerebrovascular Disease
Figure 13. Global Neuroimaging Software Market: Stroke and Cerebrovascular Disease (2021-2026) & ($ millions)
Figure 14. Neuroimaging Software in Neurodegenerative Disease and Multiple Sclerosis
Figure 15. Global Neuroimaging Software Market: Neurodegenerative Disease and Multiple Sclerosis (2021-2026) & ($ millions)
Figure 16. Neuroimaging Software in Neuro-oncology
Figure 17. Global Neuroimaging Software Market: Neuro-oncology (2021-2026) & ($ millions)
Figure 18. Neuroimaging Software in Others
Figure 19. Global Neuroimaging Software Market: Others (2021-2026) & ($ millions)
Figure 20. Global Neuroimaging Software Market Size Market Share by Application in 2025
Figure 21. Global Neuroimaging Software Revenue Market Share by Player in 2025
Figure 22. Global Neuroimaging Software Market Size Market Share by Region (2021-2026)
Figure 23. Americas Neuroimaging Software Market Size 2021-2026 ($ millions)
Figure 24. APAC Neuroimaging Software Market Size 2021-2026 ($ millions)
Figure 25. Europe Neuroimaging Software Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Neuroimaging Software Market Size 2021-2026 ($ millions)
Figure 27. Americas Neuroimaging Software Value Market Share by Country in 2025
Figure 28. United States Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Neuroimaging Software Market Size Market Share by Region in 2025
Figure 33. APAC Neuroimaging Software Market Size Market Share by Type (2021-2026)
Figure 34. APAC Neuroimaging Software Market Size Market Share by Application (2021-2026)
Figure 35. China Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 39. India Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Neuroimaging Software Market Size Market Share by Country in 2025
Figure 42. Europe Neuroimaging Software Market Size Market Share by Type (2021-2026)
Figure 43. Europe Neuroimaging Software Market Size Market Share by Application (2021-2026)
Figure 44. Germany Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 45. France Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Neuroimaging Software Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Neuroimaging Software Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Neuroimaging Software Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 58. APAC Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 59. Europe Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 61. United States Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 62. Canada Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 63. Mexico Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 64. Brazil Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 65. China Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 66. Japan Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 67. Korea Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 69. India Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 70. Australia Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 71. Germany Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 72. France Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 73. UK Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 74. Italy Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 75. Russia Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 76. Egypt Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 77. South Africa Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 78. Israel Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 79. Turkey Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 80. Global Neuroimaging Software Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Neuroimaging Software Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 1. Neuroimaging Software Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuroimaging Software Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Neuroimaging Software Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Neuroimaging Software Sales Market Share by Country/Region (2025)
Figure 8. Neuroimaging Software Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Neuroimaging Software Market Size Market Share by Type in 2025
Figure 10. Global Neuroimaging Software Market Size Market Share by Deployment Model in 2025
Figure 11. Global Neuroimaging Software Market Size Market Share by Intended Use in 2025
Figure 12. Neuroimaging Software in Stroke and Cerebrovascular Disease
Figure 13. Global Neuroimaging Software Market: Stroke and Cerebrovascular Disease (2021-2026) & ($ millions)
Figure 14. Neuroimaging Software in Neurodegenerative Disease and Multiple Sclerosis
Figure 15. Global Neuroimaging Software Market: Neurodegenerative Disease and Multiple Sclerosis (2021-2026) & ($ millions)
Figure 16. Neuroimaging Software in Neuro-oncology
Figure 17. Global Neuroimaging Software Market: Neuro-oncology (2021-2026) & ($ millions)
Figure 18. Neuroimaging Software in Others
Figure 19. Global Neuroimaging Software Market: Others (2021-2026) & ($ millions)
Figure 20. Global Neuroimaging Software Market Size Market Share by Application in 2025
Figure 21. Global Neuroimaging Software Revenue Market Share by Player in 2025
Figure 22. Global Neuroimaging Software Market Size Market Share by Region (2021-2026)
Figure 23. Americas Neuroimaging Software Market Size 2021-2026 ($ millions)
Figure 24. APAC Neuroimaging Software Market Size 2021-2026 ($ millions)
Figure 25. Europe Neuroimaging Software Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Neuroimaging Software Market Size 2021-2026 ($ millions)
Figure 27. Americas Neuroimaging Software Value Market Share by Country in 2025
Figure 28. United States Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Neuroimaging Software Market Size Market Share by Region in 2025
Figure 33. APAC Neuroimaging Software Market Size Market Share by Type (2021-2026)
Figure 34. APAC Neuroimaging Software Market Size Market Share by Application (2021-2026)
Figure 35. China Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 39. India Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Neuroimaging Software Market Size Market Share by Country in 2025
Figure 42. Europe Neuroimaging Software Market Size Market Share by Type (2021-2026)
Figure 43. Europe Neuroimaging Software Market Size Market Share by Application (2021-2026)
Figure 44. Germany Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 45. France Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Neuroimaging Software Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Neuroimaging Software Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Neuroimaging Software Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Neuroimaging Software Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 58. APAC Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 59. Europe Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 61. United States Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 62. Canada Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 63. Mexico Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 64. Brazil Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 65. China Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 66. Japan Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 67. Korea Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 69. India Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 70. Australia Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 71. Germany Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 72. France Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 73. UK Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 74. Italy Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 75. Russia Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 76. Egypt Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 77. South Africa Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 78. Israel Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 79. Turkey Neuroimaging Software Market Size 2027-2032 ($ millions)
Figure 80. Global Neuroimaging Software Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Neuroimaging Software Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Neuroimaging Software Market Size 2027-2032 ($ millions)
More Publications
Global Rabies Monoclonal Antibody Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
June 2024
84 pages
Global UHF Band Synthetic Aperture Radar Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
63 pages
Global Anti Spam Filter Software Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
108 pages
Global Mixed Reality Game Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
February 2024
129 pages
